|4Mar 19, 8:55 PM ET

Burkhart Erin 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 19, 2024

Insider Transaction Report

Form 4
Period: 2024-03-15
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2024-03-15+4,72018,814 total
  • Tax Payment

    Common Stock

    2024-03-18$83.87/sh372$31,20018,442 total
  • Award

    Stock Option (Right to Buy Common Stock)

    2024-03-15+7,0507,050 total
    Exercise: $83.87From: 2025-03-15Exp: 2034-03-14Common Stock (7,050 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted March 15, 2024. Price not applicable.
  • [F2]Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Documents

3 files